You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hu-5F9

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

Recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Stanford, California
    Stanford University
Jun 21, 2022

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Acute Myeloid Leukemia Trial in United States (Atezolizumab, Hu5F9-G4)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Sacramento, California
  • +3 more
Dec 3, 2021

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +19 more
Dec 8, 2022

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Ovarian Cancer Trial in United States (Magrolimab, Avelumab)

Completed
  • Ovarian Cancer
  • Chicago, Illinois
  • +5 more
Jul 26, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Apr 10, 2023

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Solid Tumor, Colorectal Cancer Trial in United States (Magrolimab, Cetuximab)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Los Angeles, California
  • +7 more
Feb 8, 2021

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

Recruiting
  • Pancreatic Cancer
  • +4 more
  • PET Scan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 10, 2023

Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)

Recruiting
  • Sickle Cell Disease
  • NDec - oral decitabine-tetrahydrouridine
  • +2 more
  • Oakland, California
  • +39 more
Jan 24, 2023

Carcinoma of Prostate Trial in Toronto (18F-DCFPyL)

Active, not recruiting
  • Carcinoma of Prostate
  • 18F-DCFPyL
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 31, 2022

Cervix Cancer Trial in Toronto (18F-Fluoroazomycin Arabinoside (18F-FAZA))

Active, not recruiting
  • Cervix Cancer
  • 18F-Fluoroazomycin Arabinoside (18F-FAZA)
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Oct 21, 2022

Lung Cancer Trial in Toronto (18-F-FAZA)

Recruiting
  • Lung Cancer
  • 18-F-FAZA
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Cancer Centre
Oct 6, 2022

Cough Trial in United Kingdom (BAY1817080, Matching Placebo)

Completed
  • Cough
  • North Shields, Tyne And Wear, United Kingdom
  • +6 more
Jan 24, 2023

Breast Cancer Trial in Worldwide (tamoxifen citrate, Anastrozole)

Completed
  • Breast Cancer
  • Newcastle, Australia
  • +96 more
Oct 5, 2021

Kidney Stones Trial in Guangzhou (7.5fr ultra-fine ureteroscopy, 9.2fr Ureteroscopy)

Not yet recruiting
  • Kidney Stones
  • 7.5fr ultra-fine ureteroscopy
  • 9.2fr Ureteroscopy
  • Guangzhou, Guangdong,China, China
    Department of Urology, Minimally invasive Surgery Center, The Fi
Jan 31, 2022

Exudative Macular Degeneration, Retinal Hemorrhage Trial in United Kingdom (Ranibizumab, C3F8 Gas, tPA)

Completed
  • Exudative Macular Degeneration
  • Retinal Hemorrhage
  • Maidstone, Kent, United Kingdom
  • +4 more
Jul 10, 2020

Cholesterol; Metabolic Disorder, Lipoproteinemia Trial in Nantes (infusion of tracer [5,5,5-2H3] -L-leucine)

Completed
  • Cholesterol; Metabolic Disorder
  • Lipoproteinemia
  • infusion of tracer [5,5,5-2H3] -L-leucine
  • Nantes, France
    Nantes University Hospital
Feb 22, 2022